Last $12.25 USD
Change Today -0.48 / -3.77%
Volume 1.5M
VNDA On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

vanda pharmaceuticals inc (VNDA) Snapshot

Open
$12.70
Previous Close
$12.73
Day High
$12.72
Day Low
$12.17
52 Week High
03/24/14 - $19.25
52 Week Low
10/13/14 - $8.34
Market Cap
485.7M
Average Volume 10 Days
615.5K
EPS TTM
$-1.70
Shares Outstanding
39.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for VANDA PHARMACEUTICALS INC (VNDA)

vanda pharmaceuticals inc (VNDA) Related Businessweek News

No Related Businessweek News Found

vanda pharmaceuticals inc (VNDA) Details

Vanda Pharmaceuticals Inc., a biopharmaceutical company, is engaged in the development and commercialization of pharmaceutical products. Its product portfolio includes HETLIOZ, a product for the treatment of Non-24-Hour Sleep-Wake Disorder; Fanapt, a product for the treatment of schizophrenia; and VLY-686, a small molecule neurokinin-1 receptor antagonist. The company was incorporated in 2002 and is headquartered in Washington, the District of Columbia.

60 Employees
Last Reported Date: 10/27/14
Founded in 2002

vanda pharmaceuticals inc (VNDA) Top Compensated Officers

Founder, Chief Executive Officer, President a...
Total Annual Compensation: $515.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $315.0K
Chief Medical Officer and Senior Vice Preside...
Total Annual Compensation: $279.8K
Compensation as of Fiscal Year 2013.

vanda pharmaceuticals inc (VNDA) Key Developments

Vanda Pharmaceuticals, Inc. Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-03-2014 02:30 PM

Vanda Pharmaceuticals, Inc. Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-03-2014 02:30 PM. Venue: The New York Palace Hotel, 455 Madison Ave, New York, NY 10022, United States.

Vanda Pharmaceuticals, Inc. Presents at Stifel Healthcare Conference 2014, Nov-19-2014 11:30 AM

Vanda Pharmaceuticals, Inc. Presents at Stifel Healthcare Conference 2014, Nov-19-2014 11:30 AM. Venue: The Palace Hotel, 455 Madison Ave, New York, NY 10022, United States. Speakers: James Patrick Kelly, Chief Financial Officer, Principal Accounting Officer, Senior Vice President, Treasurer and Secretary, Mihael H. Polymeropoulos, Founder, Chief Executive Officer, President and Director.

Vanda Pharmaceuticals Mulls Acquisitions

Vanda Pharmaceuticals, Inc. (NasdaqGM:VNDA) is seeking acquisitions. Vanda Pharmaceuticals is planning to raise funds from offering and plans to use part of proceeds for acquisitions too. Vanda Pharmaceuticals said, "We may also use a portion of the net proceeds to acquire or invest in businesses, products or technologies that we believe are complementary to our own."

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VNDA:US $12.25 USD -0.48

VNDA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AstraZeneca PLC 4,565 GBp -7.50
Eli Lilly & Co $72.40 USD -0.05
Pfizer Inc $31.94 USD -0.03
Sanofi €75.38 EUR -0.79
Sumitomo Dainippon Pharma Co Ltd ¥1,198 JPY +24.00
View Industry Companies
 

Industry Analysis

VNDA

Industry Average

Valuation VNDA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 9.5x
Price/Book 390.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 9.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VANDA PHARMACEUTICALS INC, please visit www.vandapharmaceuticals.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.